Talk to Pharmaxis Ltd directly.
Sign up to their Investor Hub for direct access to the Pharmaxis Ltd team, ask them questions, and see personal updates.
Pharmaxis Limited (PXS) is a specialty pharmaceutical company involved in the research, development and commercialisation of therapeutic products for chronic respiratory disorders. PXS has two approved products: Bronchitol for cystic fibrosis and Aridol diagnosis of asthma; and four products in development: PXS-4728, LOX platform technology Orbital, ASM8. Headquartered in Sydney at its Frenchs Forest manufacturing facilities, Pharmaxis also has offices in Europe and the United States. Former Names Pharmaxis Limited PXS (11/11/2003)
2/20 Rodborough Rd, Frenchs Forest NSW 2086, Australia
Earnings per share
Dividend per share